Print

Lobby looking for ways around the ruling

In the article below, EU ag Commissioner Phil Hogan says he is "surprised" by the EU Court of Justice ruling that certain new GM techniques fall under the GMO legislation. If he understood the relevant science and EU laws, he would not be so surprised. The products of new GM techniques are clearly GMOs, scientifically and legally.

It is ironic, therefore, that Hogan seems to think that "accepting science" means somehow blinding oneself to these scientific and legal facts.

He also indicates that he (and, presumably, the GMO lobby as a whole) will be looking for "legal options" to try to get around or nullify the ruling.
---

EU agriculture Commissioner ‘surprised’ by gene editing court ruling

By Sarantis Michalopoulos
EURACTIV.com, 25 Jan 2019
https://www.euractiv.com/section/agriculture-food/news/eu-agriculture-commissioner-surprised-by-gene-editing-court-ruling/

The European governments have to decide whether science or politics are applied when it comes to issues such as new plant breeding techniques (NPBTs), EU’s Commissioner for Agriculture and Rural Development Phil Hogan said.

Speaking to a group of journalists on 24 January, Hogan said, “I think 2019 will be an opportunity for overall reflection and see what the legal options are at the highest level of governments about whether we accept science or not as the basis of making decisions on these issues.”

In July 2018, the European Court of Justice (ECJ) ruled that organisms obtained by mutagenesis plant breeding technique are genetically modified organisms (GMOs) and should, in principle, fall under the GMO Directive.

The term NPBTs describes a number of scientific methods for the genetic engineering of plants to enhance factors like drought tolerance and pest resistance [See background].

The decision shocked the industry and EU farmers, who described it as a severe blow to innovation in EU agriculture and warned about economic and environmental consequences.

On the other hand, the ruling pleased environmental NGOs, which said the court ruling prevented “hidden GMOs” from entering the EU from the back door.

Asked by EURACTIV.com about his view on the ECJ decision, Hogan said he was “surprised” by the ruling.

“Health Commissioner Vytenis Andriukaitis is looking at this intensively to see what the legal options available are […] the next Commission will deal with that to see what the precise criteria are in order to give approvals and non-approvals of these products,” said Hogan.

“It’s going to be a big issue: is it going to be the application of science or the application of political opinions? What are the criteria? This political debate is on its way, the European Parliament has already engaged in this process and let’s where it goes,” he added.

Sources recently told EURACTIV that the ruling is “challenging”, considering that member states have raised many issues around it and face difficulties in understanding.

The same sources noted that it is a matter of interpretation at national level.

In October 2018, scientists from more than 85 European plant and life sciences research centres and institutes published a position paper warning about the negative consequences of the court ruling for EU agriculture.

They also asked for the revision of the GMO directive to correctly reflect scientific progress in biotechnology.

BACKGROUND

The term NPBTs describes a number of scientific methods for the genetic engineering of plants to enhance traits like drought tolerance and pest resistance.

The agri-food industry says the plants obtained through these techniques could also be the product of conventional cross-breeding techniques that mimic natural processes and hence cannot be considered GMOs.

To opponents, they are just another attempt at selling “hidden” GMOs to European farmers, who will simultaneously lose their right to use their own seeds. Their basic argument is that all these techniques should fall under the strict GMO approval process.

In 2016, France asked the European Court of Justice to clarify whether a variety of herbicide-resistant rapeseed obtained through NPBTs should follow the GMO approval process.